Please assess the completion status of the following clinical trial:

Trial Title: Medihoney and Santyl for Burn Injuries

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* New patient presenting with a partial thickness burn injury in at least two non-contiguous locations of the body.~* Enrollment will occur within 72 hours of sustaining a burn injury.~Exclusion Criteria:~* Cognitive or language barriers that preclude completion of study measures.~* Have burn injuries exceeding 40% total body surface area (TBSA).~* Have a diagnosis of immunodeficiency or kidney disease.~* Are receiving treatment (e.g., chemotherapy, dialysis) that can create concerns with immunodeficiency or affect healing.~* Are pregnant.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Medihoney & Santyl (Type: OTHER): Each patient will receive both interventions simultaneously, but on non-contiguous parts of the body that each consist of partial thickness burn injuries of similar depth. For example, if a patient presents with bilateral second-degree burns to the lower extremities, one leg will be treated with MEDIHONEY® GEL with Active leptospermum honey dressing, while the other leg will be treated with SANTYL® ointment dressing. MEDIHONEY® is the target treatment for this study, while SANTYL® is standard care.

Based on this trial design, predict the completion outcome and termination type (if applicable).